EIKON THERAPEUTICS
Dead / Abandoned — Abandoned — no statement of use filed (as of 31 Oct 2025)
What this means for you
This application is over — abandoned 31 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90690466
- Mark type
- Design + words
- Filed
- 04 May 2021
- Published for opposition
- 02 Aug 2022
- Abandoned
- 31 Oct 2025
- Attorney of record
- Ilene B. Tannen
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical drug discovery and development services; Scientific and medical research, development and information services in the fields of pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicine discovery and development; Drug discovery and pharmaceutical development services for the pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine industries; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for drug discovery and development; Providing temporary use of on-line non-downloadable software for tracking and measuring movement of proteins in living cells for pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine discovery and development services; Drug, pharmaceutical, biopharmaceutical, therapeutic, vaccine, diagnostic, and medicine research and development and testing; Research and development of new products in the fields of drugs, pharmaceuticals, biopharmaceuticals, therapeutics, vaccines, diagnostics, and medicines; Biomedical research and development services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Medical and clinical research and pharmaceutical development services to discover and develop medicines and vaccines in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Research, development, analysis, testing and consulting services in the fields of biochemistry, biotechnology, medicines, diagnostics, vaccines and pharmaceuticals; Scientific, medical, biological, biotechnology, biomedical, pharmaceutical research, development, analysis and testing services in the fields of cancer, immunological disorders, neuro-related disorders, cardio-vascular disorders, metabolic disorders, gastroenterology, dermatology, endocrinology, infectious diseases and ophthalmologic disorders; Scientific laboratory services, namely, live cell imaging analysis; Custom design and development of cells, cell lines and assays; Biomedical research services using a platform of biological tools and techniques for use in scientific research, drug and vaccine discovery and development; Providing a website featuring information in the fields of drug discovery and development, biochemistry, biotechnology, medicines, diagnostics, and pharmaceuticals; Provision of scientific, medical, biotechnology, biomedical, vaccine and pharmaceutical information regarding drug discovery, pharmaceutical products, vaccines and clinical trials
Owner
- EIKON THERAPEUTICS, INC., Millbrae, CA, US
- EIKON THERAPEUTICS, INC., Hayward, CA, US
Prosecution history
- 31 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 31 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 25 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 25 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Mar 2025 — SOU EXTENSION 5 GRANTED
- 30 Jan 2025 — SOU EXTENSION 5 FILED
- 30 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 05 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Sept 2024 — SOU EXTENSION 4 GRANTED
- 05 Sept 2024 — SOU EXTENSION 4 FILED
- 05 Sept 2024 — SOU TEAS EXTENSION RECEIVED